Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
The emergence of the COVID-19 pandemic has resulted in a very large number of infections and high number of mortality. There is no specific therapeutic options that are approved for clinical use. Administration of convalescent plasma as a possible therapy was used in the case of viral pneumonia incl...
Saved in:
Main Authors: | Jaffar A. Al-Tawfiq (Author), Yaseen Arabi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021) -
Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19)
by: Ahmed N. Alghamdi, et al.
Published: (2020) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is Not Circulating Among Hajj Pilgrims
by: Jaffar A. Al-Tawfiq, et al.
Published: (2023) -
Thinking more about therapy with convalescent plasma for COVID-19 patients
by: Guangshu Han, et al.
Published: (2020) -
Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China
by: Xingsheng Hu, et al.
Published: (2020)